ASX:NOX
Market Cap:
Price Delay ~20min
Interactive 2020
Annual Report

Media

2-Jul-2021

BiotechDispatch: Australian clinical-stage drug development company Noxopharm (ASX:NOX) has announced that the US FDA has granted Investigational New Drug (IND) approval to the DARRT-2 study.

Read More here

2-Jul-2021

Proactive: Noxopharm Ltd (ASX:NOX) is set for a very busy six months ahead with news flow expected from its Veyonda® immune-oncology drug that works with the body’s defence mechanisms to fight cancer cells. 

Read More here

15-Jun-2021

The Australian: Graham Kelly will never forget the year 2014. Some of the top cancer specialists in Australia told him that the treatments on his prostate cancer had failed and that the cancer had spread around his body.

Read More here

11-May-2021

Outsourcing-Pharma: Clinical study shows drug has COVID-19 treatment potential. CEO Dr. Graham Kelly discusses the history of Veyonda, details of the NOXCOVID study and next steps with Jenni Spinner, editor.

Read More here

30-Apr-2021

Global Pharma Update reported, "Australian company Noxopharm has reported interim data from its NOXCOVID trial, which showed that its drug candidate Veyonda provided protection against hyper-inflammation (cytokine storm) in moderate Covid-19 patients"

Read More here

30-Apr-2021

Proactive Investors reported, "Noxopharm welcomes prestigious scientific journal reporting success of Veyonda® as booster of chemotherapy in late-stage cancer patients"

Read more here.

27-Apr-2021

Biospace reported, Australian clinical-stage drug development company Noxopharm Limted (ASX:NOX) today announced that in a cohort of 18 patients with moderately severe cases of COVID-19.

Read More here

27-Apr-2021

Barron's reported: "Australian clinical-stage drug development company Noxopharm Limted (ASX:NOX) today announced that in a cohort of 18 patients with moderately severe cases of COVID-19"

Read more here.

22-Apr-2021

TrialSiteNews reported, "Noxopharm Files Septic Shock Treatment Patent for Veyonda®"

Read more here.

17-Apr-2021

SBS online reported, "Hope for men with advanced prostate cancer after Australian treatment trials".

Read more here.